Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Organizations & Institutions

Drug Manufacturers Pay European Key Opinion Leaders €153-€283 Per Hour on Average


Print article Print article

Cutting Edge Information, LLC - We answer questions that no one else can.
Cutting Edge Information, LLC - We answer questions that no one else can.
2014-08-01 17:03:14 - Regulatory Scrutiny in Europe and U.S. Driving Standardization of Compensation Tracking

Research Triangle Park, NC – A new study of European fair-market value benchmarks found that drug manufacturers spend between €153 and €283 for a typical key opinion leader (KOL) engagement in Europe, according to Cutting Edge Information.

Payments vary by company size, according to Cutting Edge Information’s data. The study found that biotechnology companies pay European thought leaders anywhere between €50 and €250 per hour, at an average rate of €153. By contrast, large pharmaceutical companies’ payments range between €75 and €600 per hour, at an average rate of €283.

The study, “Determining European KOL Compensation: Fair-Market Value Benchmarks,” details the current trends affecting physician compensation in Europe and provides guidelines for thought leader management teams to set thought leader compensation benchmarks

that are competitive and justified.

“KOL payments in Europe have been coming under increasingly intense scrutiny,” said Elio Evangelista, director of research at Cutting Edge Information. “As companies respond to greater regulation of KOL compensation in Europe, we’re seeing a gradual decline and leveling-off of hourly rates.”

A similar trend occurred in the United States as KOL compensation faced greater regulatory scrutiny. Once drug manufacturers started to focus on what they spend for KOL activities, hourly rates declined and became more consistent across companies of differing sizes. Europe is following a similar pattern, Evangelista said.

Already, the Association of the British Pharmaceutical Industry will require disclosure of physician payments for member companies by 2013. Fees requiring disclosure include those for consulting, writing, advisory board participation or speaking at public meetings. Travel and accommodation costs will also be disclosed. Drug manufacturers expect more scrutiny of thought leader compensation from the EMA and country-level regulatory bodies.

“Determining European KOL Compensation: Fair-Market Value Benchmarks” includes benchmark metrics for thought leader compensation and key opinion leader payments. The report includes strategic recommendations designed to help medical affairs, clinical development, legal and compliance executives to:

• Build a comprehensive thought leader management database.
• Calculate fair-market value and develop physician fee schedules.
• Build relationships with clinical and commercial key opinion leaders.

More information about medical affairs strategy and key opinion leader relationships and thought leaders compensation is available at www.cuttingedgeinfo.com/research/medical-affairs/european-kol-fm ...

Contact
Elio Evangelista
+1 919-403-6583


Contact Information:
Cutting Edge Information, LLC

68 TW Alexander Drive
Research Triangle Park, NC 27709

Contact Person:
Chris Inks
Head of Operations
Phone: 919-403-6583
email: email

Web: www.cutitngedgeinfo.com



Author:
Chris Inks
e-mail
Web: www.cuttingedgeinfo.com
Phone: 9194036583

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com